Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ascendis Pharma Ads (ASND)

63.81 -1.2 (-1.85%)

04-20 16:00

Open:

64.84

Pre. Close:

65.01

High:

65.61

Low:

63.515

Volume:

69,924

Market Cap:

2650M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

65.75 - 66.145

66.145 - 66.439

Low:

62.576 - 63.095

63.095 - 63.48

Close:

63.132 - 63.894

63.894 - 64.461

Technical analysis  (as of: 2018-04-20 4:27:34 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 79.72     One year: 93.11

Support:

Support1: 61.79    Support2: 57.80

Resistance:

Resistance1: 68.25    Resistance2: 79.72

Pivot:

62.06

Moving Averages:

MA(5): 64.64     MA(20): 62.58

MA(100): 52.91     MA(250): 38.96

MACD:

MACD(12,26): 0.60     Signal(12,26,9): 0.34

%K %D:

%K(14,3): 66.57     %D(3): 70.09

RSI:

RSI(14): 53.12

52-Week:

High: 69  Low: 21.95  Change(%): 127.6

Average Vol(K):

3-Month: 18152  10-Days 8610

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ASND has closed below upper band by 30.7%. Bollinger Bands are 0.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-13T01:03:46-04:00
Institutional Top Ideas Series: DAFNA Capital Management

2018-03-28T19:50:06-04:00
Ascendis Pharma's (ASND) CEO Jan Mikkelsen on Q4 2017 Results - Earnings Call Transcript

2018-03-28T16:05:39-04:00
Ascendis Pharma reports FY results

2018-03-27T17:35:00-04:00
Notable earnings after Wednesdays close

2018-03-19T07:30:00-04:00
PRO+ Weekly Digest: Focusing On Short Ideas Following The Market Rebound

2018-03-17T08:47:14-04:00
Stocks To Watch: Wake-Up Call For The IPO Market

2018-03-16T10:26:29-04:00
Key events next week - healthcare (continued #1)

2018-02-23T08:00:00-05:00
Your Daily Pharma Scoop: Dynavax Achieves Major Milestone, GW Pharmaceuticals GWP42006 Fails, Sangamo Signs Deal With Gilead's Kite Unit

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

41.52

Shares Float (M)

41.52

% Held by Insiders

% Held by Institutions

79.20

Shares Short (K)

550

Shares Short Prior Month (K)

330

Stock Financials

EPS

-4.170

EPS Est. Current Year

-0.140

EPS Est. Next Year

0.140

EPS Est. Next Quarter

0.020

Forward EPS

-3.930

Book Value (p.s.)

11.180

PEG Ratio

-0.55

Profit Margin

Operating Margin

-7290.26

Return on Assets (ttm)

-65.6

Return on Equity (ttm)

-72.4

Qtrly Rev. Growth

-73.2

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.146

Qtrly Earnings Growth

Operating Cash Flow (M)

-116.94

Levered Free Cash Flow (M)

-68.39

atoplab.com

Valuation

P/E

-15.30

P/E Growth Ratio

-0.02

P/BV

5.71

P/S

44156522496.00

P/CF

-22.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.